Transfusion Thresholds
Coagulopathy
- Most cirrhotics with abnormal coagulation studies do not require a transfusion1-3
- INR does not accurately reflect the bleeding risk in cirrhotics4
- Decreased liver synthesis of pro-coagulant factors is often balanced by the decreased synthesis of anti-coagulants. There is also a compensatory elevation in Factor VIII and Von Willebrand factor. This complex milieu is not accurately reflected by an INR or aPTT. 5
- A more accurate indication of bleeding risk is clinically apparent bleeding like an active GI bleed, epistaxis, oozing around IV’s, or large hematomas
- In general, the goal INR < 2.5
- 1,000 consecutive outpatient paracenteses had no bleeding complications despite 67% of patients having an INR 1.5-2.56
- 50% of hepatologist never use FFP prior to paracentesis, or only use FFP if the INR > 2.51
Thrombocytopenia
- In general, the goal platelets > 30,000
- Absolute platelet count in cirrhotics also does not predict bleeding risk
- 1,000 consecutive outpatient paracenteses had no bleeding complications despite 50% of patients having platelets between 30,00-50,0006
- Platelet function is upregulated in cirrhotics by an abundance of Factor VIII and Von Willebrand factor5
- Qualitative platelet defects do predict severe bleeding7
- Consider DDAVP, platelet transfusion, small gauge needle, and/or delaying paracentesis if
- Uremic renal failure
- Aspirin or other antiplatelet agent
- Consider DDAVP, platelet transfusion, small gauge needle, and/or delaying paracentesis if
High Bleeding Risk
Avoid paracentesis in cirrhotics with DIC and Hyperfibrinolysis3
- Disseminated Intravascular Coagulation
- Difficult to diagnose in cirrhotics because of the abnormal fibrinogen, platelets, and coagulation studies at baseline
- Look for schistocytes or reduced Factor VIII levels
- Transfuse FFP and cryoprecipitate as needed
- Fibrinolysis
- Up to 30% of cirrhotics in ICU have hyperfibrinolysis8
- Low fibrinogen alone is not diagnostic
- Euglobulin lysis is diagnostic, but takes 4-7 days to result
- Clinical Signs
- Suspect hyperfibrinolysis if clinically significant mucosal bleeding or massive bruising
- Post procedure bleeding that is delayed by several hours is classic for hyperfibrinolysis
- The initial platelet plug is functional, but then breaks down as fibrin is lysed
- Transfuse cryoprecipitate and use Aminocaproic Acid as needed
Next Page
References
- Runyon, B.A. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 49, 2087-107 (2009).
- Thomsen, T.W., Shaffer, R.W., White, B. & Setnik, G.S. Videos in clinical medicine. Paracentesis. N Engl J Med 355, e21 (2006).
- Wong, C.L., Holroyd-Leduc, J., Thorpe, K.E. & Straus, S.E. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA 299, 1166-78 (2008).
- Ewe, K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 26, 388-93 (1981).
- Tripodi, A. & Mannucci, P.M. The coagulopathy of chronic liver disease. N Engl J Med 365, 147-56 (2011).
- Grabau, C.M. et al. Performance standards for therapeutic abdominal paracentesis. Hepatology 40, 484-8 (2004).
- Pache, I. & Bilodeau, M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther 21, 525-9 (2005).
- Hu, K.Q., Yu, A.S., Tiyyagura, L., Redeker, A.G. & Reynolds, T.B. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 96, 1581-6 (2001).